SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026048
Filing Date
2021-05-10
Accepted
2021-05-10 16:08:37
Documents
66
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cue-10q_20210331.htm   iXBRL 10-Q 1428126
2 EX-31.1 cue-ex311_6.htm EX-31.1 16411
3 EX-31.2 cue-ex312_10.htm EX-31.2 16670
4 EX-32.1 cue-ex321_9.htm EX-32.1 10510
5 GRAPHIC gin0o13y45s0000001.jpg GRAPHIC 37145
  Complete submission text file 0001564590-21-026048.txt   6193319

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cue-20210331.xsd EX-101.SCH 53333
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cue-20210331_cal.xml EX-101.CAL 39239
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cue-20210331_def.xml EX-101.DEF 176673
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20210331_lab.xml EX-101.LAB 407472
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20210331_pre.xml EX-101.PRE 313269
11 EXTRACTED XBRL INSTANCE DOCUMENT cue-10q_20210331_htm.xml XML 990737
Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38327 | Film No.: 21907218
SIC: 2834 Pharmaceutical Preparations